Desert King
  • Home
  • About Us
  • Raw Materials
    • Quillaja Management
    • Yucca Management
    • Jojoba Management
  • Lines of Business
    • Pharmaceuticals
    • Animal Nutrition and Health
    • Food and Beverages
    • Personal Care and Cosmetics
    • Agriculture
    • Environment and Mining
  • Quality
  • News
  • Contact
  • English
  • Spanish
The Natural Choice The Natural Choice The Natural Choice The Natural Choice
  • Home
  • About Us
  • Raw Materials
    • Quillaja Management
    • Yucca Management
    • Jojoba Management
  • Lines of Business
    • Pharmaceuticals
    • Animal Nutrition and Health
    • Food and Beverages
    • Personal Care and Cosmetics
    • Agriculture
    • Environment and Mining
  • Quality
  • News
  • Contact
  • English
  • Spanish

Scientific Papers

 Rodrigues, K.A., et al. Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion.
0
By Desert King
In Scientific Papers
Posted 7 July, 2025

Rodrigues, K.A., et al. Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion.

Rodrigues, K.A., et al. Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion. Sci Transl Med, 2025 Jun 18, [...]

READ MORE
 Taquet, M., et al. Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections.
0
By Desert King
In Scientific Papers
Posted 7 July, 2025

Taquet, M., et al. Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections.

Taquet, M., et al. Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections. NPJ Vaccines, 2025 Jun 25, 10(1):130. PMID: 40562756 The [...]

READ MORE
 Hayek, H., et al. Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy.
0
By Desert King
In Scientific Papers
Posted 11 June, 2025

Hayek, H., et al. Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy.

Hayek, H., et al. Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy. Transpl Infect Dis, 2025 May 19, e70053. PMID: 40387162 This comprehensive review discusses the [...]

READ MORE
 Hu, J., et al. Herpes simplex virus 1 fusion glycoprotein B H516P prefusion mutation had no effect on vaccine immunogenicity.
0
By Desert King
In Scientific Papers
Posted 11 June, 2025

Hu, J., et al. Herpes simplex virus 1 fusion glycoprotein B H516P prefusion mutation had no effect on vaccine immunogenicity.

Hu, J., et al. Herpes simplex virus 1 fusion glycoprotein B H516P prefusion mutation had no effect on vaccine immunogenicity. Vaccine, 2025 May 31, 57:127241. PMID: 40354699 This study [...]

READ MORE
 Shi, P., et al. Discovery of novel adjuvants: Identification of saponins from Hylomecon japonica (Thunb.) Prantl & Kündig and insights into their in vitro and in vivo activities.
0
By Desert King
In Scientific Papers
Posted 10 June, 2025

Shi, P., et al. Discovery of novel adjuvants: Identification of saponins from Hylomecon japonica (Thunb.) Prantl & Kündig and insights into their in vitro and in vivo activities.

Shi, P., et al. Discovery of novel adjuvants: Identification of saponins from Hylomecon japonica (Thunb.) Prantl & Kündig and insights into their in vitro and in vivo activities. Bioorg Chem, [...]

READ MORE
 Lu, X., et al. Natural products targeting tumour angiogenesis.
0
By Desert King
In Scientific Papers
Posted 10 June, 2025

Lu, X., et al. Natural products targeting tumour angiogenesis.

Lu, X., et al. Natural products targeting tumour angiogenesis. Br J Pharmacol, 2025 May, 182(10):2094-2136. PMID: 37680009 This comprehensive review highlights the potential of natural products [...]

READ MORE
 Alves, K., et al. Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study.
0
By Desert King
In Scientific Papers
Posted 10 June, 2025

Alves, K., et al. Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study.

Alves, K., et al. Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a [...]

READ MORE
 Natama, H.M., et al. Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children.
0
By Desert King
In Scientific Papers
Posted 10 June, 2025

Natama, H.M., et al. Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children.

Natama, H.M., et al. Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children. [...]

READ MORE
 Cao, H., et al.  A QS21 + CpG-Adjuvanted Trivalent HSV-2 Vaccine and Trivalent HSV-2 mRNA Vaccine Induce a Strong Immune Response, Protect Against HSV-2 Infection, and Cross-Protect Against HSV-1 Infection in Mice.
0
By Desert King
In Scientific Papers
Posted 10 June, 2025

Cao, H., et al. A QS21 + CpG-Adjuvanted Trivalent HSV-2 Vaccine and Trivalent HSV-2 mRNA Vaccine Induce a Strong Immune Response, Protect Against HSV-2 Infection, and Cross-Protect Against HSV-1 Infection in Mice.

Cao, H., et al.  A QS21 + CpG-Adjuvanted Trivalent HSV-2 Vaccine and Trivalent HSV-2 mRNA Vaccine Induce a Strong Immune Response, Protect Against HSV-2 Infection, and Cross-Protect Against HSV-1 [...]

READ MORE
 Adeagbo, B.A., et al. Lyophilization Strategy Enhances the Thermostability and Field-Based Stability of Conjugated and Comixed Subunit Liposomal Adjuvant-containing Tuberculosis Vaccine Formulation (ID93 + GLA-LSQ).
0
By Desert King
In Scientific Papers
Posted 9 May, 2025

Adeagbo, B.A., et al. Lyophilization Strategy Enhances the Thermostability and Field-Based Stability of Conjugated and Comixed Subunit Liposomal Adjuvant-containing Tuberculosis Vaccine Formulation (ID93 + GLA-LSQ).

Adeagbo, B.A., et al. Lyophilization Strategy Enhances the Thermostability and Field-Based Stability of Conjugated and Comixed Subunit Liposomal Adjuvant-containing Tuberculosis Vaccine [...]

READ MORE

DESERT KING INTERNATIONAL
745 Main Street-
Chula Vista, CA, USA, 91911
+1 619 429 5222
info@desertking.com

DESERT KING CHILE
Avenida Industrial 1970
Quilpué, Chile, 2420505
+56 32 292 5020
info@desertking.cl

DESERT KING MEXICO
Camino Vecinal 11500-A
Tijuana B.C., México, 22664
+52 664 636 11 24
info@desertkingmexico.com

Privacy Policy
© 2025 Desert King. All Right Reserved

Start typing and press Enter to search